Stocks · Health care · Biological Products, (No Diagnostic Substances)

Apogee Therapeutics, Inc.

APGE Clue Score20
United States Fiscal year ends December CIK 0001974640 Results filed 10 Aug 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Mark C. McKenna
12 Dec 2024
Director
Buy
12,500
$49.85
$623.13K
Mark C. McKenna
12 Dec 2024
Director
Buy
7,500
$49.02
$367.65K
Fairmount Funds Management LLC
13 Jul 2023
Director
Buy indirect
892,529
$17.00
$15.17M
Fairmount Funds Management LLC
13 Jul 2023
Director
Buy indirect
1,992,734
$17.00
$33.88M
Fairmount Funds Management LLC
13 Jul 2023
Director
Buy indirect
55,913
$17.00
$950.52K
Nimish P Shah
13 Jul 2023
Director
Buy indirect
1,750,000
$17.00
$29.75M

What was left out

Form 4 filings counted 113
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 9
Sales on a Rule 10b5-1 plan 95
Sales straight out of an exercise 34
Sales at will 2
Transactions with no price 0
Shares from compensation/vesting 4,853,766
History held since 17 Jul 2023